Tumour microenvironment: Remodelling resistance

Nature Reviews Cancer

Volumn 7, Issue 1, 2007, Pages 7-

  Alderton, Gemma ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; KCC 009; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ASTROCYTOMA; BRAIN REGION; BRAIN TISSUE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL SURFACE; CELL SURVIVAL; COMBINATION CHEMOTHERAPY; CORRELATION ANALYSIS; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RNA INTERFERENCE;

EID: 33845875717     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc2055     Document Type: Article

References (1)

1. Yuan, L. et al. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene 13 November 2006 (doi:10.1038/sj.onc.1210048)